Canyam
AI summaries for academic research
Home
Preprint
Subscribe
Favorites
Tools
Analysis
Summary
Not logged in
Back
Journal Details
Pharmacoeconomics
IF
4.6
Papers
214
Citations
7336
Related Insights
0
subscribe
Journal Papers
189
Related Insights
0
Journal Papers
189
Publication Date
Publication Date
IF
Citations
Missing Data in Trial-Based Cost-Effectiveness Analysis: The Journey Continues
Pharmacoeconomics
IF
4.6
2026-08-12
0
PRE
AI
Jiunn Wang; Baptiste Leurent; Manuel Gomes
Share
Save
Fail to Compare, Prepare to Fail: Comparator Omission in NICE Single Technology Appraisals
Pharmacoeconomics
IF
4.6
2026-08-07
0
PRE
AI
Frank Grimsey Jones; Saul Stevens; Dawn Lee
Share
Save
The End of ‘Pay-and-Hope’: Managing Accelerated Approvals with Outcomes-Based Reimbursement in the Era of Routinely Collected Health Data
Pharmacoeconomics
IF
4.6
2026-08-06
0
PRE
AI
Giovanni Tramonti; Peter S. Hall
Share
Save
External Validation of SELECT Trial-Derived Cardiovascular Risk Equations in a UK Population with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes
Pharmacoeconomics
IF
4.6
2026-08-03
0
OA
AI
Felice Gragnano; Martin Bøg; Anders Bo Bojesen; Milana Ivkovic; Christopher Lübker; Francesco Fusco; Resham Baruah; Joseph Whitaker; Nia C. Jenkins; Iestyn Lloyd; Steffan Hill; Peter E. Weeke; A. Michael Lincoff
Share
Save
A Machine Learning and Large Language Model Tool for Systematic Literature Reviews of Health Economic Evidence: A Validation Study
Pharmacoeconomics
IF
4.6
2026-07-29
0
PRE
AI
Lisa M. Bloudek; Allie B. Cichewicz; Kush Patel; Sean D. Sullivan; Kevin M. Kallmes
Share
Save
Uncertainty in Economic Evaluation: A Pragmatic Guide for Health Technology Assessment (HTA) Agencies in Resource-Constrained Settings
Pharmacoeconomics
IF
4.6
2026-07-23
0
OA
AI
Siobhan Botwright; Syarifah Liza Munira; Itamar Megiddo; Nouran El Desouky; Lucky Gift Ngwira; Hugo C. Turner; Yot Teerawattananon
Share
Save
Comparing User-Written Codes for Performing Economic Evaluations in Stata
Pharmacoeconomics
IF
4.6
2026-07-17
0
PRE
AI
Bradley Barker-Jones; Patricia Navvuga; Petra Baji; Elsa Marques; William Hollingworth
Share
Save
Inhaled Levodopa for the Management of OFF Episodes in Parkinson’s Disease: A Cost-Effectiveness Analysis
Pharmacoeconomics
IF
4.6
2026-07-15
0
OA
AI
Daniel Evans; Chetan Mistry; Harun Knight; Rushab Shah; Leandro Guerra-Primo; Hanne C Gadeberg; Stefano Perni; Wendy Clarke; Julie Brown; Georg-Alexander Pietsch; Ubong Silas; Camille Carroll
Share
Save
Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Practical Guidance
Pharmacoeconomics
IF
4.6
2026-07-14
0
OA
AI
Jennifer D. Zwicker; Ramesh Lamsal; Myla E. Moretti; Wendy J. Ungar
Share
Save
Endovascular Treatment for Acute Ischemic Stroke: A Methodological Systematic Review of Health Economic Decision Modeling Studies
Pharmacoeconomics
IF
4.6
2026-07-13
0
OA
AI
Andreas Beisel; Hans-Helmut König; Judith Dams
Share
Save
Optimisation or Restriction? Unpacking the Logic Behind NICE Decisions
Pharmacoeconomics
IF
4.6
2026-07-13
0
OA
AI
Nadine Henderson; Brittany Darrow; Phill O’Neill; Martina Garau
Share
Save
Correction: Development of a Patient-Level Multi-objective Optimisation Model for Screening Strategies for Childhood Type 1 Diabetes
Pharmacoeconomics
IF
4.6
2026-07-10
0
PRE
AI
Gonçalo Leiria; R. Brett McQueen; Conner Jackson; Marian Rewers; William A. Hagopian; Richard A. Oram; Jonathan E. Fieldsend; Lauric A. Ferrat
Share
Save
Cost-Utility Analyses of Systemic Treatments for Psoriasis and Psoriatic Arthritis in the UK: A Systematic Review of Modelling Methods
Pharmacoeconomics
IF
4.6
2026-07-08
0
PRE
AI
Thomas S. Clemmet; Duc Binh Phan; Alice Copson; Richard B. Warren; Zenas Z. N. Yiu; Gabriel Rogers
Share
Save
Use and Outcomes of Cost-Effectiveness Analyses and Additional Considerations in Pharmaceutical Reimbursement in the Netherlands
Pharmacoeconomics
IF
4.6
2026-07-07
0
OA
AI
Diederik Brokkelkamp; Vivian Reckers-Droog; Lonneke Timmers; Pieter van Baal
Share
Save
SMART Planning of Early-Stage Health Economic Decision Models for Mechanism-Based Precision Treatments in Rare Cancers: An Application and Tool Update
Pharmacoeconomics
IF
4.6
2026-07-06
0
OA
AI
Teebah Abu-Zahra; Sabine E. Grimm; Prashant Changoer; Nicolas U. Gerber; Stephanie Mathes; Romana T. Netea-Maier; Manuela Joore
Share
Save
Balancing Access and Value in Multi-Indication Medicines: Implications of PD-L1 Broad Listings in Australia
Pharmacoeconomics
IF
4.6
2026-06-23
0
OA
AI
Isaiah Luc; Drew Carter; Tracy Merlin
Share
Save
Applications of Structural Expert Elicitations for Economic Evaluations: A Systematic Review Update
Pharmacoeconomics
IF
4.6
2026-06-19
0
OA
AI
Benjamin P. Geisler; Fredrik Holmboe; Irene Starinieri; Eline Aas
Share
Save
Community Pharmacist Preferences for Providing a Dose Administration Aid Service in Australia: A Discrete Choice Experiment
Pharmacoeconomics
IF
4.6
2026-06-16
0
OA
AI
Rakhee Raghunandan; Parisa Aslani; Timothy F. Chen; Sarah Norris; Andrea Torres-Robles; Noriko Sato; Kirsten Howard
Share
Save
A Critical Systematic Review of Modelling Approaches and Methodologies used in Hyperlipidaemia Economic Evaluations
Pharmacoeconomics
IF
4.6
2026-06-15
0
OA
AI
Karl Vivoda; Harvey Koh; Tamrat Befekadu Abebe; Sheridan Rodda; Chris Bain; Zanfina Ademi
Share
Save
Deriving a Korean SF-6Dv2 Value Set Using a Discrete Choice Experiment with Duration
Pharmacoeconomics
IF
4.6
2026-06-11
0
PRE
AI
Eun-Young Bae; Jahyun Cho; Jooho Moon; Brendan Mulhern; Donna Rowen; Jakob Bue Bjorner; Min-Woo Jo
Share
Save